Prazocip 2.5 XL Tablet
By Prazocip
Rx
15 Tablet ER in a Strip

Composition
Prazosin(2.5mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
August, 2025

liver
Prazocip 2.5 XL Tablet requires caution when used by individuals with liver disease. It may be necessary to adjust the dosage of Prazocip 2.5 XL Tablet for patients with liver issues. It is important to consult your doctor for guidance on the appropriate use of this medication in such cases.

kidney
Prazocip 2.5 XL Tablet is generally considered safe for use in patients with kidney disease, as per limited data. Dosage adjustment may not be necessary, but it's important to consult your doctor. Starting with a low dose and monitoring blood pressure regularly is recommended for potential dose adjustments.

alcohol
When taking Prazocip 2.5 XL Tablet, be careful since it can lead to increased drowsiness when consumed with alcohol.

driving
When using Prazocip 2.5 XL Tablet, be careful as it can decrease alertness, affect vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Prazocip 2.5 XL Tablet is considered unsafe during pregnancy. Animal studies indicate potential harm to the baby. Your doctor will assess risks versus benefits before prescribing. Please consult your doctor.

breastfeeding
Prazocip 2.5 XL Tablet may not be safe to use while breastfeeding. Limited evidence shows potential harm to the baby through passing into breastmilk.
Habit Forming | No |
Chemical Class | Piperazine Derivative |
Therapeutic Class | - |
Action Class | Adrenergic receptor (alpha) antagonist- selective |
₹80.36
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024